- Social networks and prostate cancer treatment norms.
- Drug pulled off market after $1 billion in sales.
- Cato on med mal.
- The customer is always right.
- Pfizer earnings vs. Counterfeit drugs.
Early November Links
Written By: Jason Shafrin
-
Nov•
03•11
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.